3,016 reports of this reaction
3.1% of all GLIPIZIDE TABLETS reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for GLIPIZIDE TABLETS, manufactured by ANI Pharmaceuticals, Inc.. There are 3,016 FDA adverse event reports linking GLIPIZIDE TABLETS to DRUG INEFFECTIVE. This represents approximately 3.1% of all 96,589 adverse event reports for this drug.
Patients taking GLIPIZIDE TABLETS who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among GLIPIZIDE TABLETS users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for GLIPIZIDE TABLETS:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 3,016 FDA reports for GLIPIZIDE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.1% of all adverse event reports for GLIPIZIDE TABLETS, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking GLIPIZIDE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.